Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel-Carboplatin vs Gemcitabine-Cisplatin in PS2 NSCLC
NCT00006004Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Aug 2000
- Primary completion
- Jan 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 4
01
Overview
A Phase 2 trial of paclitaxel, carboplatin, gemcitabine, cisplatin in non-small cell lung cancer (NSCLC), sponsored by Eastern Cooperative Oncology Group. Started Aug 2000; status: completed.
02
Drugs
paclitaxelcarboplatingemcitabinecisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00006004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006004.